JPMORGAN CHASE & CO - REVANCE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330909. A total of 4 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,528
-47.1%
2,400
+50.0%
0.00%–
Q1 2023$52,000
-94.7%
1,600
-97.7%
0.00%–
Q2 2022$973,000
-77.0%
70,400
-67.5%
0.00%
-100.0%
Q1 2022$4,224,000
+35.1%
216,600
+13.0%
0.00%–
Q4 2021$3,127,000–191,600–0.00%–
 Download
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 36,400$1,032,0000.00%
SIMPLEX TRADING, LLC 226$640,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REVANCE THERAPEUTICS INC shareholders